文献速递牙周病

慢性牙周炎中产生IL-37及IL-35/IL-37的浆细胞

IL-37- and IL-35/IL-37-Producing Plasma Cells in Chronic Periodontitis.
PubMed 文献 · J Dent Res · 2019-05-03

研究用免疫组化检测慢性牙周炎(CP)牙龈组织中IL-35和IL-37水平,发现CD138+CD38+浆细胞是主要免疫细胞类型并产生这两种抗炎细胞因子。体外实验显示重组IL-35和IL-37剂量依赖性抑制破骨细胞形成(300 ng/mL时抑制约78.9%和97.7%,P < 0.05),提示这些浆细胞亚群可能通过阻断破骨细胞形成调控牙槽骨丢失。

要点

  • CP牙龈中IL-35和IL-37水平显著高于健康组织。
  • CD138+CD38+浆细胞是CP牙龈主要免疫细胞并产生IL-35/IL-37。
  • IL-35和IL-37剂量依赖性抑制破骨细胞形成。

核心结论

  • CP病变中存在产生IL-37及共产生IL-35/IL-37的浆细胞亚群,可能通过抑制破骨细胞形成调控牙周炎骨丢失。

研究设计与样本

  • 采用免疫组化检测CP与健康牙龈组织中IL-35和IL-37水平,并用免疫荧光和共聚焦显微镜鉴定浆细胞亚群。

主要发现

  • CP牙龈组织中IL-35和IL-37水平显著高于健康组织。
  • CD138+CD38+浆细胞是CP牙龈主要免疫细胞类型,并产生IL-35和IL-37。
  • 鉴定出CD138+CD38+PIL-37和CD138+CD38+PIL-35/IL-37两个浆细胞亚群,均为IgG+浆细胞。
  • 人重组IL-35和IL-37剂量依赖性抑制体外破骨细胞形成,300 ng/mL时抑制率分别约78.9%和97.7%(P < 0.05)。

临床怎么用

  • 提示浆细胞来源的IL-35和IL-37可能作为牙周炎骨丢失的潜在调控靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Periodontitis is one of the most prevalent chronic inflammatory diseases and is induced by the interaction between oral microorganisms and the host immune system. Plasma cells are of special interest in chronic periodontitis (CP), as they represent ~50% of infiltrated immune cells in periodontal lesions. Plasma cells constitute the only known cell type capable of antibody production; however, recent evidence supports an emerging role for distinct sets of plasma cells in cytokine production. However, the presence of cytokine-producing plasma cells in CP is unknown. In this study, we used immunohistochemistry to detect significantly elevated levels of IL-35 and IL-37 (2 recently identified anti-inflammatory cytokines) in CP gingival tissue as compared with healthy tissue. Remarkably, we demonstrate that CD138+ CD38+ plasma cells are the major immune cell type in CP gingival tissues and that these cells produce IL-35 and IL-37. We used immunofluorescence and confocal microscopy analysis to identify a subset of plasma cells with robust cytoplasmic expression of IL-37-we denote this subset as IL-37-producing plasma cells (CD138+CD38+PIL-37). Another subset of plasma cells coproduces IL-35 and IL-37 and is denoted as IL-37/IL-35-coproducing plasma cells (CD138+CD38+PIL-35/IL-37). We determined that these 2 plasma cell subsets are IgG+plasma cells. Moreover, we show that human recombinant IL-35 and IL-37 exhibit a dose-dependent inhibition of osteoclast formation in vitro (~78.9% and 97.7% inhibition in 300 ng/mL of IL-35 and IL-37, respectively, P < 0.05). Overall, our findings suggest that PIL-37 and PIL-35/IL-37 exist as subsets of plasma cells in CP lesions and that these 2 new types of plasma cells may regulate periodontitis pathogenesis by inhibiting alveolar bone loss through directly blocking osteoclast formation. Importantly, these data suggest a novel role of plasma cells and offer potential new mechanistic and regulatory targets to be investigated in the context of periodontal health and disease.

来源:J Dent Res,查看原文。版权归原作者所有。

引用

  1. Jing L, Kim S, Sun L, et al. IL-37- and IL-35/IL-37-Producing Plasma Cells in Chronic Periodontitis. J Dent Res. 2019. PMID: 31050915. doi:10.1177/0022034519847443

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。